M2 Macrophages or IL-33 Treatment Attenuate Ongoing Mycobacterium Tuberculosis Infection

Scientific Reports - United Kingdom
doi 10.1038/srep41240
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of IL-10 and TNF-α During Mycobacterium Tuberculosis Infection in Murine Alveolar Macrophages

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Treatment of Latent Infection With Mycobacterium Tuberculosis: Update 2010

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

The Biology of Mycobacterium Tuberculosis Infection.

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2013English

Analysis of Differentially Expressed Proteins in Mycobacterium Avium-Infected Macrophages Comparing With Mycobacterium Tuberculosis-Infected Macrophages

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

BCG and Infection With Mycobacterium Tuberculosis

Thorax
PulmonaryRespiratory Medicine
2014English

Mycobacterium Marinum: A Potential Immunotherapy for Mycobacterium Tuberculosis Infection

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

Regulation of L-Type Voltage Gated Calcium Channel CACNA1S in Macrophages Upon Mycobacterium Tuberculosis Infection

PLoS ONE
Multidisciplinary
2015English

Phenotypic Assays for Mycobacterium Tuberculosis Infection

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2017English

Boosting Effect of IL-7 in Interferon Gamma Release Assays to Diagnose Mycobacterium Tuberculosis Infection

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy